United States
China
India
Japan
Singapore
South Africa
United Kingdom
As a leading publisher of trusted science, technology, medicine, humanities and social sciences research, Taylor & Francis is committed to helping public health authorities, researchers, clinicians and the general public contain and manage the spread of COVID-19.
This microsite provides links and references to all relevant COVID-19 research articles, book chapters and information that can be freely accessed on Taylor & Francis Online and Taylor & Francis ebooks in support of the global efforts in diagnosis, treatment, prevention and further research into COVID-19. As signatories to NIH’s Access to Research initiative, along with the Wellcome Trust’s coordinated action on sharing research data and findings relevant to the outbreak, Taylor & Francis has been working with WHO to ensure this content is clearly signposted. We are also aligning the OSTP’s initiative to centralise resources on PubMed and are currently working with them to ensure rapid human and machine-readable access (where possible) to research articles and data through the NLM’s LitCovid portal.
More research in this field has been collated by colleagues at F1000Research, through a dedicated Gateway which showcases research published in this area, including preprints, to ensure immediate access to the latest research developments https://f1000research.com/gateways/disease_outbreaks/coronavirus
Prioritising rapid publication of COVID-19 materials
We are working with our editors to prioritise peer review of all relevant research. We are also focusing our workflow to ensure that materials related to the outbreak are fast-tracked through the publication process once they are approved. Editors are proactively encouraging authors to publish and share the data that forms the basis of their research in line with FAIR data principles, and our own data policies.
We are continually monitoring the developments of the coronavirus and spread of COVID-19, and we will continue to update the content on this site on a regular basis.
Journals
1-242 of 4,900+ results.
Access the full Coronavirus Research Archive
- article-commentaryStrategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines
- research-articleBamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection
- review-articleEmerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
- research-articleCurrent and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19)
- research-articleSARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19)
- research-articleCOVID-19 transmission risk factors
- review-articleVitamin D and COVID-19: where are we now?
- research-articleAntibody levels remain high to one-year’s follow-up after moderate and severe COVID-19, but not after mild cases
- research-articleHydroxychloroquine as pre-exposure prophylaxis against COVID-19 infection among healthcare workers: a prospective cohort study
- research-articleConvalescent plasma treatment in severely immunosuppressed patients hospitalized with COVID-19: an observational study of 28 cases
- review-articleExploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
- research-articleInhaled interferons beta and SARS-COV2 infection: a preliminary therapeutic perspective
- otherPoint-of-care COVID-19 testing in the emergency department: current status and future prospects
- research-articleCorrespondence regarding: TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
- research-articleAssessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study
- research-articleCOVID-19 vaccine equity: a health systems and policy perspective
- research-articleAnaemia and enhancement of coagulation are associated with severe COVID-19 infection
- research-articleRole of hemagglutinin esterase in replication of SARS-CoV-2
Books
- research-articleCelecoxib, Glipizide, Lapatinib, and Sitagliptin as potential suspects of aggravating SARS-CoV-2 (COVID-19) infection: a computational approach
- research-articleThe role of autophagy in the pathogenesis of SARS-CoV-2 infection in different cell types
- research-articleImmunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy
- otherResponse to letter to the editor: the clinical utility of diagnostic T cell assays for COVID-19
- otherIndomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19
- research-articleFerritin as prognostic marker in COVID-19: the FerVid study
- research-articleThe clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center
- research-articleTherapeutic strategies for Covid-19 based on molecular docking and dynamic studies to the ACE-2 receptors, Furin, and viral spike proteins
- research-articleHigh rate of bacterial respiratory tract co-infections upon admission amongst moderate to severe COVID-19 patients
- research-articleIdentification of potent inhibitors against transmembrane serine protease 2 for developing therapeutics against SARS-CoV-2
- research-articleLower plasma calcium associated with COVID-19, but not with disease severity: a two-centre retrospective cohort study
- otherTherapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19
- research-articleInvestigation of MBL2 and NOS3 functional gene variants in suspected COVID-19 PCR (–) patients
- research-articleCan Anakinra and corticosteroid treatment be an effective option in pregnant women with severe Covid-19?
- rapid-communicationDuplex formation between the template and the nascent strand in the transcription-regulating sequences is associated with the site of template switching in SARS – CoV-2
- research-articleArjunetin as a promising drug candidate against SARS-CoV-2: molecular dynamics simulation studies
- research-articleAntibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh
- research-articleAntibody response to the first dose of AZD1222 vaccine in COVID-19 convalescent and uninfected individuals in Bangladesh
- research-articleDrug repositioning against COVID-19: a first line treatment
- research-articleDetection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition
- review-articleNuts and bolts of COVID-19 associated coagulopathy: the essentials for management and treatment
- research-articleUnderstanding the molecular interaction of SARS-CoV-2 spike mutants with ACE2 (angiotensin converting enzyme 2)
- research-articleFeaturing ACE2 binding SARS-CoV and SARS-CoV-2 through a conserved evolutionary pattern of amino acid residues
- research-articleIn silico prediction of natural compounds as potential multi-target inhibitors of structural proteins of SARS-CoV-2
- research-articleDiscovery of novel inhibitors of SARS-CoV-2 main protease
- research-articleRelation of interleukin-6 levels in COVID-19 patients with major adverse cardiac events
- otherTo mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination
- research-articleMyxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein
- research-articleMyxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein
- research-articleAssociation between Vitamin D Status and Risk of Developing Severe COVID-19 Infection: A Meta-Analysis of Observational Studies
- research-articleAn overview of the preclinical discovery and development of remdesivir for the treatment of coronavirus disease 2019 (COVID-19)
- research-articleThe role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism
- research-articleCOVID-19 clinical phenotypes and short-term outcomes: differences between the first and the second wave of pandemic in Italy
- research-articleRepurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2
- research-articleTocilizumab for the treatment of non‐critical COVID‐19 pneumonia: an overview of the rationale and clinical evidence to date
- article-commentarySARS-CoV-2 vaccination in the context of original antigenic sin
- research-articleHuman immunoglobulin from transchromosomic bovines hyperimmunized with SARS-CoV-2 spike antigen efficiently neutralizes viral variants
- research-articleTocilizumab in COVID-19: a study of adverse drug events reported in the WHO database
- research-articleBlood concentrations of proapoptotic sFas and antiapoptotic Bcl2 and COVID-19 patient mortality
- research-articleAssociation between Hb A1c and Severity of COVID-19 Patients
- research-articleEmerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies
- research-articleIntegrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors
- research-articleIntegrated docking and enhanced sampling-based selection of repurposing drugs for SARS-CoV-2 by targeting host dependent factors
- research-articlePerformance of the FREND™ COVID-19 IgG/IgM Duo point-of-care test for SARS-CoV-2 antibody detection
- research-articleReported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST)
- otherUnleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination
- research-articleMolecular modeling of potent novel sulfonamide derivatives as non-peptide small molecule anti-COVID 19 agents
- research-articleChemical system biology approach to identify multi-targeting FDA inhibitors for treating COVID-19 and associated health complications
- research-articleAre the new SARS-CoV-2 variants resistant against the vaccine?
- research-articleHospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
- research-articleThe role of IL-6 and IL-6 blockade in COVID-19
- research-articlePotential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations
- research-articleEngineering a multi epitope vaccine against SARS-CoV-2 by exploiting its non structural and structural proteins
- research-articleVirtual screening of quinoline derived library for SARS-COV-2 targeting viral entry and replication
- review-articleLong COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- research-articleMarine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery
- research-articleDistinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19
- research-articleA large-scale computational screen identifies strong potential inhibitors for disrupting SARS-CoV-2 S-protein and human ACE2 interaction
- research-articlePerspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection
- research-articleThe Glasgow Prognostic Score and fibrinogen to albumin ratio as prognostic factors in hospitalized patients with COVID-19
- research-articleComputational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings
- otherTapping the immunological imprints to design chimeric SARS-CoV-2 vaccine for elderly population
- case-reportHemorrhagic infarctive stroke in COVID-19 patients: report of two cases and review of the literature
- review-articleCOVID-19 pericarditis mimicking an acute myocardial infarction: a case report and review of literature
- article-commentaryExperimental studies using OMV in a new platform of SARS-CoV-2 vaccines
- research-articleOutcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis
- article-commentaryIs a single COVID-19 vaccine dose enough in convalescents ?
- Original ResearchStructural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach
- Original ResearchDesign of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach